AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionCito Capital Group, LLC
Latest Disclosed Ownership20,280 shares
Latest Disclosed Value $ 4,411
Cito Capital Group, LLC reports 4.16% increase in ownership of 4AB / AbbVie Inc.

On May 14, 2026 - Cito Capital Group, LLC filed a 13F-HR form disclosing ownership of 20,280 shares of AbbVie Inc. (DE:4AB) valued at $3,759,912 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 19,470 shares of AbbVie Inc.. This represents a change in shares of 4.16% during the quarter. The current value of the position is $3,822,780 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ABBVIE COM 00287Y109 20,280 810 4.16 4 0.00 1.3535
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 19,470 7 0.04 4 0.00 1.2984
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 19,463 11 0.06 5 33.33 1.3063
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 19,452 360 1.89 4 -25.00 1.2565
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 19,092 10 0.05 4 33.33 1.5200
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 19,082 210 1.11 3 0.00 1.2481
2024-11-13 2024-09-30 13F ABBVIE COM 00287Y109 18,872 -1,790 -8.66 4 0.00 1.3911
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 20,662 11 0.05 4 0.00 1.3742
2024-05-15 2024-03-31 13F ABBVIE COM 00287Y109 20,651 11 0.05 4 0.00 1.5407
2024-02-14 2023-12-31 13F ABBVIE COM 00287Y109 20,640 12 0.06 3 0.00 1.3713
2023-11-15 2023-09-30 13F ABBVIE COM 00287Y109 20,628 1,710 9.04 3 50.00 1.4881
2023-08-14 2023-06-30 13F ABBVIE COM 00287Y109 18,918 12 0.06 3 -33.33 1.1680
2023-05-15 2023-03-31 13F ABBVIE COM 00287Y109 18,906 10 0.05 3 0.00 1.5020
2023-02-10 2022-12-31 13F ABBVIE COM 00287Y109 18,896 62 0.33 3 50.00 1.6792
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 18,834 10 0.05 3 0.00 1.4498
2022-08-15 2022-06-30 13F ABBVIE COM 00287Y109 18,824 10 0.05 3 -33.33 1.5758
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 18,814 -489 -2.53 3 50.00 1.3934
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 19,303 11 0.06 3 0.00 1.0917
2021-11-10 2021-09-30 13F ABBVIE COM 00287Y109 19,292 -6,488 -25.17 2 0.00 0.9731
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 25,780 11 0.04 3 0.00 1.3079
2021-05-17 2021-03-31 13F ABBVIE COM 00287Y109 25,769 163 0.64 3 0.00 1.3619
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 25,606 706 2.84 3 -99.91 1.3842
2020-11-16 2020-09-30 13F ABBVIE COM 00287Y109 24,900 3,134 14.40 2,181 2.06 1.2179
2020-08-11 2020-06-30 13F ABBVIE COM 00287Y109 21,766 1,866 9.38 2,137 40.96 1.3847
2020-05-15 2020-03-31 13F ABBVIE COM 00287Y109 19,900 900 4.74 1,516 -9.87 1.2165
2020-02-13 2019-12-31 13F ABBVIE COM 00287Y109 19,000 0 0.00 1,682 16.89 1.1007
2019-11-14 2019-09-30 13F ABBVIE COM 00287Y109 19,000 -1,000 -5.00 1,439 -1.03 1.0397
2019-08-14 2019-06-30 13F ABBVIE COM 00287Y109 20,000 2,000 11.11 1,454 0.21 1.0698
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 18,000 500 2.86 1,451 -10.04 1.0649
2019-02-11 2018-12-31 13F ABBVIE COM 00287Y109 17,500 0 0.00 1,613 -2.54 1.3318
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 17,500 1,500 9.38 1,655 11.67 1.1360
2018-07-02 2018-06-30 13F ABBVIE COM 00287Y109 16,000 0 0.00 1,482 -2.11 1.1100
2018-05-14 2018-03-31 13F ABBVIE COM 00287Y109 16,000 0 0.00 1,514 -2.13 1.1481
2018-02-12 2017-12-31 13F ABBVIE COM 00287Y109 16,000 0 0.00 1,547 8.87 1.1479
2017-11-13 2017-09-30 13F ABBVIE COM 00287Y109 16,000 16,000 1,422 1.1179
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.